Service
-
For Authors
How to submit, copyright, proposals, discount.
-
For Librarians
Ejournals, ebooks, collections, pricing, usage statistics.
-
For Book Reviewers
How to request a book,
terms and conditions.
Our (e)Books and (e)Journals
IOS Press serves the information needs of scientific and medical communities worldwide. See what's new and browse our books and journals to learn more.
Browse by Subject
IOS Press publishes books and journals (online and in print) in a broad range of scientific, technical and medical (STM) subject areas. Click on a subject above to see our titles.
Service
-
For Authors
How to submit, copyright, proposals, discount.
-
For Librarians
Ejournals, ebooks, collections, pricing, usage statistics.
-
For Book Reviewers
How to request a book,
terms and conditions.
News
Keep me informedLD Connect Beta Version 2 Now Available from IOS Press
October 16, 2019 - Amsterdam/Santa Barbara – IOS Press is pleased to announce the availability of LD Connect 2.0 (Beta). This linked data portal with an improved user interface currently contains linked IOS Press (meta)data from more than 132,000 journal articles and book chapters and over 330,000 authors resulting in more than 16 million triples.
October 16, 2019How and Why Does Parkinson’s Disease Affect Women and Men Differently?
September 25, 2019 - Amsterdam, NL – There is growing evidence that Parkinson's disease (PD) affects women and men differently. In this insightful review, published in the Journal of Parkinson's Disease, scientists present the most recent knowledge about these sex-related differences and highlight the significance of estrogens, which play an important role in the sex differences in PD.
September 25, 2019Alzheimer’s Memory Loss Reversed by New Head Device Using Electromagnetic Waves
September 17, 2019 - Phoenix, AZ, USA – There is finally some encouraging news for the millions of Americans suffering from Alzheimer’s disease. NeuroEM Therapeutics today announced findings from an open label clinical trial showing reversal of cognitive impairment in Alzheimer’s Disease patients after just two months of treatment using the company’s wearable head device for in-home treatment. Results demonstrate that TEMT was safe in all eight participating patients with mild to moderate AD and enhanced cognitive performance in seven of them, as measured by their ADAS-cog score, which is the benchmark for testing AD therapeutics. The open access study is published in the new issue of the Journal of Alzheimer’s Disease.
September 17, 2019Exercise Could Slow Withering Effects of Alzheimer’s
September 17, 2019 - Dallas, TX, USA – Exercising several times a week may delay brain deterioration in people at high risk for Alzheimer’s disease, according to a study that scientists say merits further research to establish whether fitness can affect the progression of dementia. Research from UT Southwestern found that people who had accumulation of amyloid beta in the brain – a hallmark of Alzheimer’s disease – experienced slower degeneration in a region of the brain crucial for memory if they exercised regularly for one year.
September 17, 2019